Initial Public Offering

„We are on the brink of making it possible for diabetics worldwide to measure their blood glucose level precisely and non-invasively for the first time ever. With our new product 'D-Pocket', daily pricking will not be necessary for them anymore. So we will be setting an unrivaled standard in one of the most attractive growth markets with currently more than 400 million diabetics.“

Thorsten Lubinski, CEO von DiaMonTech

IPO questions: +49 30 - 275 870 52
IPO questions:
+49 30 - 275 870 52

Please enter your location/residence here:

Sie haben "Germany" ausgewählt. Möchten Sie auf die deutsche Seite wechseln?

DISCLAIMER – IMPORTANT

ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY DIAMONTECH AG IN GOOD FAITH AND ARE FOR INFORMATION PURPOSES ONLY.

THESE MATERIALS ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS LOCATED IN THE UNITED STATES OR RESIDENT OR LOCATED IN AUSTRALIA, CANADA, JAPAN, OR PERSONS IN ANY OTHER JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THE MATERIALS TO WHICH YOU ARE SEEKING ACCESS WOULD BREACH ANY APPLICABLE LAW OR REGULATION OR WOULD REQUIRE ANY REGISTRATION OR LICENSING WITHIN SUCH JURISDICTION.

Please read this notice carefully – it applies to all persons who view this webpage. Please note that the disclaimer set out below may be altered or updated. You should read it in full each time you visit the site.

Viewing the materials you are seeking to access may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view such materials. Any persons who wish to view these materials must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict them from doing so.

The information in the following pages is not intended for, and is not to be made available to, persons in the United States, Australia, Canada, or Japan. Any announcements regarding securities offerings, or references to securities offerings, that are contained on these pages do not constitute an offering of those securities. Any offering of securities will be contained in the prospectus that contains detailed information about the issuer and the offered securities, including a discussion of risks, the issuer’s business and relevant financial information.

The materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada, Japan or in any jurisdiction in which such offers or sales are unlawful. Any securities issued in connection with an offering have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any applicable securities laws of any state, province, territory, county or jurisdiction of the United States, Australia, Canada, or Japan. Accordingly, unless an exemption under relevant securities laws is applicable, any such securities may not be offered, sold, resold, taken up, exercised, renounced, transferred, delivered or distributed, directly or indirectly, in or into the United States, Australia, Canada, Japan or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration of such securities in, the relevant jurisdiction. There will be no public offer of securities in the United States.

In member states of the European Economic Area ("EEA") other than Germany, these materials are only addressed to and directed at persons who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC) ("Qualified Investors"). This information must not be acted on or relied on in any member state of the EEA other than Germany by persons who are not Qualified Investors. In any member state of the EEA other than Germany, any investment or investment activity to which this information relates is only available to Qualified Investors, and will be engaged only with such persons.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage. These materials must not be, released or otherwise forwarded, distributed or sent in or into the United States, Australia, Canada, Japan or any jurisdiction where the distribution of these materials would breach any applicable law or regulation or would require any registration or licensing within such jurisdiction. Persons receiving such documents (including custodians, nominees and trustees) must not distribute or send them in, into or from the United States, Australia, Canada, or Japan.

Basis of access

Access to electronic versions of these materials is being made available on this webpage by DiaMonTech AG in good faith and for information purposes only. Any person seeking access to this webpage represents and warrants to DiaMonTech AG that they are doing so for information purposes only. Making press announcements and other documents available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy securities in DiaMonTech AG. Further, it does not constitute a recommendation by DiaMonTech AG or any other party to sell or buy securities in DiaMonTech AG.

Confirmation of understanding and acceptance of disclaimer

By clicking on the "AGREE" button, I warrant that I am not located in the United States and am not resident or located in Australia, Canada, or Japan or any other jurisdiction where accessing these materials is unlawful, and I agree that I will not transmit or otherwise send any materials contained in this website to any person in the United States, Australia, Canada, Japan or any other territory where to do so would breach applicable local law or regulation or would require registration or licensing within such jurisdiction.

I have read and understood the disclaimer set out above. I understand that it may affect my rights and I agree to be bound by its terms. By clicking on the "AGREE" button, I confirm that I am permitted to proceed to electronic versions of the materials.

Your data will be held by DiaMonTech AG and processed only to ensure our compliance with applicable regulations.


AGREEDENY

IMPORTANT INFORMATION

You have indicated that you are not located in Germany or the United States. These materials are not intended for, directed at or accessible by persons located outside Germany. However, persons located in jurisdictions other than the United States, Australia, Canada, or Japan that make the below certifications can access these materials. Please read the certifications below carefully in order to receive these materials. If you cannot make the below certifications, please exit this page.

CERTIFICATIONS

For users located within the EEA

"We are located or resident in a member state of the European Economic Area ("EEA") in which the Prospectus Regulation is applicable (each, a "Relevant Member State") and are 'qualified investors' within the meaning of Article 2(e) the Prospectus Regulation ("Qualified Investors"). For these purposes, the expression "Prospectus Regulation" means Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC. Further, if we are acting as a fiduciary or agent for one or more investor accounts, (a) each such account is a Qualified Investor, (b) we have investment discretion with respect to each account, and (c) we have full power and authority to make the representations, warranties, agreements and acknowledgements herein on behalf of each such account."

By clicking "AGREE" below, you are certifying that the certifications and information provided are true and accurate, that you would like to access the materials. You agree that the materials you receive are for your own use and will not be released, published or distributed to any person (other than persons in your organisation who are not located or resident in the United States, Australia, Canada, Japan or any other jurisdiction in which it would be unlawful to do so).

For users outside the US, Australia, Canada, Japan and EEA who are able, under locally applicable law, to access the materials

"We confirm that we are an institutional investor and are not located or resident in the United States, Australia, Canada, Japan or any jurisdiction in which it would be unlawful for us to access the prospectus (the "Prospectus") and other offer materials published by DiaMonTech AG in connection with its initial public offering of ordinary shares which are available on this website (the "Offer Materials"). We confirm that our accessing the Offer Materials, including the Prospectus, is lawful and in accordance with the laws of the jurisdiction in which we are located or resident and we confirm that we will not, nor are we authorised to, deliver, release, publish or distribute the Prospectus or the other Offer Materials, electronically or otherwise, in or into any jurisdiction or to any other person."

By clicking "AGREE" below, you are certifying that the certifications and information provided are true and accurate, that you would like to access the materials. You agree that the materials you receive are for your own use and will not be delivered, released, published or distributed to any person (other than persons in your organisation who are not located or resident in the United States, Australia, Canada, Japan or any other jurisdiction in which it would be unlawful to do so).

Your data will be held by DiaMonTech AG and processed only to ensure our compliance with applicable regulations.


AGREEDENY

IPO News

DiaMonTech announces price range for IPO

Berlin, 13 Nov 2019

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

DiaMonTech announces price range for IPO

  • DiaMonTech shares to be offered within price range of 32.00 euros to 38.00 euros per share
  • Medical technology company with method for non-invasive blood glucose measurement expects issue volume of up to 68 million euros, assuming full exercise of the over-allotment option ("greenshoe option")
  • Offering of up to 1,796,875 shares consisting of 1,562,500 new shares from a capital increase and up to 234,375 shares pursuant to a greenshoe option
  • Proceeds from the IPO shall be invested in particular in the further product development, the start of serial production as well as marketing and sales
  • Offer period expected to run from 14 November to 26 November 2019
  • Subscriptions can be made via the Xetra Tool "Direct Place" of the Frankfurt Stock Exchange from 14 November to 25 November 2019
  • The first trading day on the regulated market (Prime Standard) of the Frankfurt Stock Exchange planned for 29 November 2019

Berlin, 13 November 2019 - Die DiaMonTech AG ("DiaMonTech" or the "Company"), a young medical technology company, has set the price range for its planned Initial Public Offering (IPO) on the Frankfurt Stock Exchange (Prime Standard) at 32.00 euros to 38.00 euros per share.

MOREDOWNLOAD PRESS RELEASE

DiaMonTech sets price range for IPO at 32.00 euros to 38.00 euros per share

MOREDOWNLOAD PRESS RELEASE

DiaMonTech plans IPO to finance growth

MOREDOWNLOAD PRESS RELEASE

Notification of denial of access

We regret that for legal reasons we cannot grant you access to this area of our website.

Click here to return to the start page.

Prospectus

Prospectus for the Public Offer of
DiaMonTech AG
Berlin, Germany

Price Range: EUR 32.00 – EUR 38.00
International Securities Identification Number (ISIN): DE000A255G44
German Securities Identification Number (WKN): A25 5G4
Ticker Symbol: 3XW

More information can be found here

Media Presentation

DiaMonTech AG is a medical technology company that specializes in the development, design and sale of products for medical diagnostics. The patented photothermal detection technology based on infrared lasers enables the precise measurement of relevant blood parameters. The first application is the non-invasive blood glucose measurement, which enables an accurate and fast measurement without pain.

More information about DiaMonTech can be found here